Impressive potential with 30 to 40 mio new patients globally every year. No drugs currently available. Novel approach from NYR in this study. lf successful for humans, this drug can improve quality of life for an enormous amount of people and set NYR up for a market cap in the billions.
- Forums
- ASX - By Stock
- Ann: Significant Neuroprotection in NYR Preclinical Brain Injury
NYR
nyrada inc.
Add to My Watchlist
0.00%
!
37.0¢

Impressive potential with 30 to 40 mio new patients globally...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1642 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 682527 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1642 | 0.370 |
1 | 30000 | 0.355 |
1 | 2857 | 0.350 |
2 | 45000 | 0.340 |
3 | 425000 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 682527 | 2 |
0.380 | 14932 | 2 |
0.385 | 36511 | 1 |
0.395 | 75000 | 3 |
0.400 | 77111 | 3 |
Last trade - 14.40pm 31/07/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
Day chart unavailable